Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Origin

Geographical scope

Document language

Publisher

Category

Organisation (author)

Search tool

Displaying 1 - 20 of 21

Document library

EMCDDA framework and practical guidance for naming synthetic cannabinoids

08.11.2022

This work provides a theoretical framework and a practical hands-on guideline for consistent naming of synthetic cannabinoids, which is easy to understand and can be applied by the forensic community, researchers, clinical practitioners, and policy-makers.

Document library

Commission Delegated Directive (EU) 2021/802 on MDMB-4en-PINACA and 4F-MDMB-BICA

09.06.2021

This document links to the Commission Delegated Directive (EU) 2021/802 on MDMB-4en-PINACA and 4F-MDMB-BICA.

Document library

Commission Delegated Directive on isotonitazene

13.11.2020

Isotonitazene is a synthetic opioid analgesic and is closely related to etonitazene and clonitazene, both of which are under international control under the 1961 United Nations Single Convention on Narcotic Drugs, as amended by the 1972 Protocol.

Document library

Document library: COPOLAD early warning systems (EWS) on NPS and emerging drug phenomena

01.06.2020

This manual was developed with the goal of promoting and facilitating the establishment of Early Warning Systems (EWSs) and agreements for information exchange between National Drug Councils, National Drug Observatories and other key institutions in CELAC (Community of Latin American and Caribbea

Document library

Council Decision on cyclopropylfentanyl and methoxyacetylfentanyl

28.09.2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats (2)(3).

Document library

Council Decision on ADB-CHMINACA

14.05.2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on CUMYL-4CN-BINACA

14.05.2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Regulation (EU) 2017/2101

15.11.2017

The legislation includes a stronger EU Early Warning System (EWS) and a faster risk-assessment process. The developments are in response to the recent growth in the market in NPS and follow a proposal from the European Commission (EC) comprising:

Document library

Council Decision on furanylfentanyl

15.11.2017

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on acryloylfentanyl

25.09.2017

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on MDMB-CHMICA

27.02.2017

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on α-PVP

27.06.2016

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on 4,4′-DMAR and MT-45

08.10.2015

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Counci Decision on 25I-NBOMe, AH-792, MDPV and methoxetamine

08.10.2015

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on 5-IT

08.10.2015

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on 4-MA

08.10.2015

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on mephedrone

02.12.2010

This Council decision requests that Member States take the necessary measures, in accordance with their national law, to submit 4-methylmethcathinone (mephedrone) to control measures and criminal penalties, as provided for under their legislation complying with their obligations under the 1971 Un

Document library

Council Decision on BZP

03.03.2008

Council Decision 2008/206/JHA of 3 March 2008 on defining 1-benzylpiperazine (BZP) as a new psychoactive substance which is to be made subject to control measures and criminal provisions. BZP is a synthetic substance. It was first reported in the European Union in 1999.

Document library

Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances

10.05.2005

This Council decision, developed under the Italian, Irish and Dutch presidencies in 2003 and 2004, replaces

Document library

Council Decision on 2C-I, 2C-T-2, 2C-T-7 and TMA-2

27.11.2003

Council Decision of 27 November 2003 defining 2C-I, 2C-T-2, 2C-T-7 and TMA-2 as new synthetic drugs, to be made subject to control measures and criminal penalties. This decision is based on the EMCDDA risk assessment of the four substances.
Loading